Search inside HIV AIDS
24/7 Customer Support
AN EMERGING VACCINE STRATEGY INVOLVES IMMUNIZING PEOPLE WITH A SERIES OF DIFFERENT ENGINEERED HIV PROTEINS AS IMMUNOGENS TO TEACH THE IMMUNE SYSTEM TO PRODUCE BROADLY NEUTRALIZING ANTIBODIES AGAINST HIV.
Its range of applications has widened in recent years to cover breast cancer (Herceptin (trastuzumab)), HIV/ AIDS (Selzentry (maraviroc)), and Cardiovascular diseases (Coumadin (warfarin)).
Diagnosing HIV/ AIDS in the initial phase of infection provides better opportunities for treatment.
IN ITS MOST RECENTLY PUBLISHED DATA, THE CENTERS FOR DISEASE CONTROL AND PREVENTION ESTIMATES OVER ##. ## MILLION PEOPLE ARE LIVING WITH HIV/ AIDS IN THE U. S.